The biomedical research commercialization training seminar

Thursday, October 14, 2021 10:00 am - 3:00 pm EDT (GMT -04:00)

CREATE Training in Global Biomedical Technology Research and Innovation: biomedical commercialization training seminar

NSERC CREATE Training in Global Biomedical Technology Research and Innovation: The biomedical research commercialization training seminar

This special training seminar features seven distinguished speakers. Learn more about idea generation, translational research, intellectual property, research commercialization, business development, and on-campus resources that can help you develop novel solutions and build an entrepreneurial mindset.

Program and Schedule

Time Speaker Title Learning objectives
10:00a.m. - 11:00a.m.

Roderick Slavcev, PhD
Professor, School of Pharmacy at the University of Waterloo; Director of Translational Initiatives at the Science Innovation Hub; CSO at Mediphage Bioceuticals Inc, and CEO of Theraphage.

Nafiseh Nafissi, PhD
Executive VP, Research & Development at Mediphage Bioceuticals.

"From industrious grad to industrial grade: An entrepreneurial and introspective workshop on translation of science from academia to industry."

Learn how to translate health technologies and build effective business models for commercializing your research. [Module 3: Biomedical Commercialization; Innovation and Challenges in Biomedical Technologies].

11:00a.m. - 12:00p.m.

Sandra Keys
Liaison librarian for Accounting & Finance and Economics, University of Waterloo.

Kathy Szigeti
Subject librarian for chemical information, University of Waterloo.

"Finding patents and conducting market research."

Learn about patents, their place as intellectual property, and how to search for them. Learn how to conduct market research, including some of the tools and resources the Library has to offer to assist. [Module 3: Biomedical Commercialization; Entrepreneurship and Commercialization].

12:00p.m. - 1:00p.m.


1:00p.m. - 2:00p.m.

Okechukwu (Okey) Igboeli, PhD
Director of the Science and Business Program at the University of Waterloo. Founder of the WatSolve Consulting Group.

"Idea to market - fundamentals of turning ideas into viable products and services."

Attendees will learn several key steps required for a successful entrepreneurial journey. Topics include: the fundamentals of idea generation, business model development, and product validation. [Module 3: Biomedical Commercialization; Entrepreneurship and Commercialization].

2:00p.m. - 2:00p.m.

John Dick, PhD
Director, Velocity Campus, University of Waterloo.

Christine Moffat
Researcher, The Problem Lab, University of Waterloo.

"Next steps: Finding problems and commercializing solutions with Velocity Campus."

Learn about on-campus programs that train students to find important problems, develop novel solutions, and build an entrepreneurial mindset. [Module 3: Biomedical Commercialization; Entrepreneurship and Commercialization].


Roderick Slavcev
Roderick Slavcev, PhD

Roderick Slavcev, PhD, is an associate Professor at the UW School of Pharmacy, a member of the Centre for Bioengineering & Biotechnology, Waterloo Institute of Nanotechnology, Centre for Eye and Vision and Director of Translational Initiatives. Roderick’s interests are in genetics, molecular biology, virology and technology transfer. His research projects focus on therapeutic bacteriophage-based biotechnology and include the use of coliphages and phage genetic elements to design and construct platforms for the development of novel vaccines, pharmaceuticals and gene delivery systems, as well as the identification and application of novel phage genomic anti-bacterial genes with potential phage therapy applications.

Roderick is also the founder and Chief Technology Officer of Mediphage Bioceuticals and brings over 25 years of research experience in both academic and industrial settings. He is a co-inventor of Mediphage’s ministring DNA platform technology and is responsible for planning and directing all aspects of the organization’s technical product, platform, and solutions. Roderick continues to guide ongoing product development, strategic direction, and applications of the core technology. Roderick is a Chartered Biologist and has a PhD in microbial genetics and an MBA in biotechnology management.

Nafiseh Nafissi
Nafiseh Nafissi, PhD

Nafiseh Nafissi, PhD, is the Executive VP of R&D at Mediphage Bioceuticals, and the co-inventor of Mediphage’s ministring DNA platform technology and its production system. Nafiseh holds a PhD. in Pharmaceutical Sciences from University of Waterloo, executive leadership certificate from AdMare Academy’s Executive Institute with 15 years of both academic and industrial experience working on various preclinical projects. Nafiseh is a collaborative leader who likes to bring innovative ideas to life. She is a dynamic researcher, and a highly driven Molecular Biologist and Microbiologist with a strong passion for biotechnology asset commercialization. She has over three years of executive management experience in the pharmaceutical industry.

At Mediphage, she leads and overseas the strategic R&D directions and applications of the core technology, therapeutic design and development, manufacturing process development, establishing and managing partnerships, and developing and managing Mediphage’s patent portfolio. Nafiseh set up the R&D department at Mediphage by establishing and training a multidisciplinary and diverse discovery, R&D, and PD team to carry out activities, including the optimization of msDNA platform technology, large-scale msDNA manufacturing and QC, and preclinical development of multiple projects.

Sandra Keys
Sandra Keys

Sandra Keys is the liaison librarian for Accounting & Finance and Economics and is currently filling in for the Entrepreneurship Librarian, Rachel Figueredo, until her return from leave later this year. In her pre-Waterloo life, she spent many years working in Investment Banking libraries in Toronto.

Kathy Szigeti
Kathy Szigeti

Kathy Szigeti is the subject librarian for chemical information. In this capacity she helps researchers find and understand patents.

Okechukwu Igboeli
Okechukwu (Okey) Igboeli, PhD

Okechukwu (Okey) Igboeli, PhD, is a Continuing Lecturer and the Director of the Science and Business Program at the University of Waterloo. He teaches several science and business courses, and facilitates the integration of science and business students’ experience with entrepreneurial activities on campus and in the community. He has significant academic and practical experience in entrepreneurship and research commercialization. Prior to joining the Science and Business program, he founded and led the drug discovery company, True Spring Pharmaceuticals Inc.

John Dick
John Dick, PhD

John Dick, PhD, is the Director of Velocity Campus at the University of Waterloo. He oversees the operations of Concept, Problem Lab, and Zero Experience programming on campus and is in charge of creating inspiring experiences for students who are interested in entrepreneurship and innovation. Before joining Velocity, John was a cofounder of Nicoya where he led its R&D efforts for 7 years as CSO. John holds a Masters of Chemical Engineering from McGill University and a PhD in Materials from the Imperial College of London. He recently completed his MBA from Lazaridis School of Business and Economics.

Christine Moffatt
Christine Moffatt

Christine Moffatt is a Researcher at the Problem Lab at the University of Waterloo, Canada’s first lab dedicated to problem analysis. She supports the Problem Lab by designing and developing new programs and hands-on workshops, coaching student innovators through the Quantum Valley Investments® Problem Pitch, and researching new areas of interest for internal and external partners. She holds a Master of Library and Information Science (MLIS) degree from Western University, and has more than ten years of experience working with small businesses and entrepreneurs.